Publications by authors named "Veronica Teleanu"

Claim this Profile
G
Gene expression-based prediction of pazopanib efficacy in sarcoma.
Christoph E Heilig, Andreas Laßmann, Sadaf S Mughal, Andreas Mock, Sebastian Pirmann, Veronica Teleanu

Eur J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.
Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, Andreas Mock, Sebastian Uhrig, Veronica Teleanu

Nat Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu

Genes Chromosomes Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Veronica Teleanu

Cancer Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu

Pathologe· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial.
Hartmut Döhner, Argiris Symeonidis, Dries Deeren, Judit Demeter, Miguel A Sanz, Veronica Teleanu

Hemasphere· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Variant interpretation in molecular pathology and oncology : An introduction].
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu

Pathologe· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of mutational signatures with yet another package for signature analysis.
Daniel Hübschmann, Lea Jopp-Saile, Carolin Andresen, Stephen Krämer, Zuguang Gu, Veronica Teleanu

Genes Chromosomes Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib is effective in the treatment of a patient with refractory T-ALL.
Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E Heilig

EJHaem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline SDHB-inactivating mutation in gastric spindle cell sarcoma.
Christoph E Heilig, Peter Horak, Daniel B Lipka, Andreas Mock, Sebastian Uhrig, Veronica Teleanu

Genes Chromosomes Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation.
Sibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, Frank G Rücker, Susanne Lux, Veronica Teleanu

Nat Commun· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal Myelomatosis: A Rare but Devastating Manifestation of Multiple Myeloma Diagnosed Using Cytology, Flow Cytometry, and Fluorescent in situ Hybridization.
Martin Bommer, Miriam Kull, Veronica Teleanu, Phyllis Schwarzwälder, Manuela Feuring-Buske

Acta Haematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual transformation of primary extranodal marginal zone B cell lymphoma of the uterus into a nodal follicular lymphoma grade IIIB.
Alexander Grunenberg, Peter Möller, Andreas Viardot, Veronica Teleanu, Dagmar Eiermann

Ann Hematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Peter Paschka, Richard F Schlenk, Daniela Weber, Axel Benner, Lars Bullinger, Veronica Teleanu

Leukemia· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromothripsis is linked to alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype.
Frank G Rücker, Anna Dolnik, Tamara J Blätte, Veronica Teleanu, Aurélie Ernst

Haematologica· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repair.
Julia K Herzig, Lars Bullinger, Alpaslan Tasdogan, Philipp Zimmermann, Martin Schlegel, Veronica Teleanu

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations.
Walter Fiedler, Sabine Kayser, Maxim Kebenko, Melanie Janning, Jürgen Krauter, Veronica Teleanu

Br J Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.
Richard F Schlenk, Sabine Kayser, Lars Bullinger, Guido Kobbe, Jochen Casper, Veronica Teleanu

Blood· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
Jan Krönke, Lars Bullinger, Veronica Teleanu, Florian Tschürtz, Verena I Gaidzik

Blood· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Stefan Gröschel, Richard F Schlenk, Jan Engelmann, Veronika Rockova, Veronica Teleanu

J Clin Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.
Frank G Rücker, Richard F Schlenk, Lars Bullinger, Sabine Kayser, Veronica Teleanu

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
Sabine Kayser, Manuela Zucknick, Konstanze Döhner, Jürgen Krauter, Claus-Henning Köhne, Veronica Teleanu

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis